Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-89
SponsorCentre hospitalier de l'Université de Montréal (CHUM)

About this trial

This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions.

The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operating room.

Eligibility criteria

Qualifiers

indication of undergoing a screening, surveillance, or diagnostic colonoscopy

Age 45-89 years

Disqualifiers

Patients undergoing emergency colonoscopy

Patients with a known familial polyposis syndrome or a known inflammatory bowel disease

Trial design

Treatments tested in this trial

  • Medtronic-GI genius (CADe system for detecting colorectal polyps)

Treatment groups

1,596 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Centre hospitalier de l'Université de Montréal (CHUM)

Lead sponsor

McGill University

Collaborator

University of British Columbia

Collaborator

Université de Sherbrooke

Collaborator

University of Alberta

Collaborator